Literature DB >> 25451228

PACAP inhibits tumor growth and interferes with clusterin in cervical carcinomas.

Ji-Hae Lee1, Ji-Yeon Lee1, Seung Bae Rho2, Jong-Soon Choi3, Dong-Gi Lee3, Sungwhan An4, Taejeong Oh4, Don-Chan Choi5, Seung-Hoon Lee6.   

Abstract

Secretory clusterin (sCLU), an anti-apoptotic protein, is overexpressed in many tumors and enhances tumorigenesis and chemo-resistance. However, the regulation mechanism controlling the sCLU maturation process or activity remains undetermined. In this study, we found PACAP as a negative regulator of CLU. Overexpression of the PACAP gene in cervical cancer cell lines lacking PACAP expression significantly inhibited cell growth and induced apoptosis. We further demonstrated that interaction of PACAP with CLU significantly downregulated CLU expression and secretion, inhibited the Akt-Raf-ERK pathway, and suppressed the growth of human tumor xenografts in nude mice. This novel inhibitory function of PACAP may be applicable for developing novel molecular therapies for tumors with increased sCLU expression.
Copyright © 2014 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Akt/Raf/ERK pathway; Apoptosis; Cervical cancer; Clusterin; Pituitary adenylate cyclase-activating polypeptide

Mesh:

Substances:

Year:  2014        PMID: 25451228     DOI: 10.1016/j.febslet.2014.11.004

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  12 in total

1.  Epigenetic control of cancer by neuropeptides.

Authors:  Karina Galoian; Parthik Patel
Journal:  Biomed Rep       Date:  2016-11-08

Review 2.  Therapeutic potential of marine peptides in cervical and ovarian cancers.

Authors:  Salman Ahmed; Haroon Khan; Sajad Fakhri; Michael Aschner; Wai San Cheang
Journal:  Mol Cell Biochem       Date:  2021-12-02       Impact factor: 3.396

Review 3.  The role and function of CLU in cancer biology and therapy.

Authors:  Yefei Zhang; Xiang Lv; Liming Chen; Yan Liu
Journal:  Clin Exp Med       Date:  2022-09-13       Impact factor: 5.057

Review 4.  Vasoactive intestinal peptide/pituitary adenylate cyclase activating polypeptide, and their receptors and cancer.

Authors:  Terry W Moody; Bernardo Nuche-Berenguer; Robert T Jensen
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2016-02       Impact factor: 3.243

5.  Examination of PACAP-Like Immunoreactivity in Urogenital Tumor Samples.

Authors:  Andrea Tamas; Andras Javorhazy; Dora Reglodi; Donat Peter Sarlos; Daniel Banyai; David Semjen; Jozsef Nemeth; Beata Lelesz; Daniel Balazs Fulop; Zalan Szanto
Journal:  J Mol Neurosci       Date:  2015-10-10       Impact factor: 3.444

6.  eIF3f reduces tumor growth by directly interrupting clusterin with anti-apoptotic property in cancer cells.

Authors:  Ji-Yeon Lee; Hyun-Ji Kim; Seung Bae Rho; Seung-Hoon Lee
Journal:  Oncotarget       Date:  2016-04-05

7.  Light-Triggerable Liposomes for Enhanced Endolysosomal Escape and Gene Silencing in PC12 Cells.

Authors:  Wenjie Chen; Wei Deng; Ewa M Goldys
Journal:  Mol Ther Nucleic Acids       Date:  2017-04-21

8.  Therapeutic role of meloxicam targeting secretory clusterin-mediated invasion in hepatocellular carcinoma cells.

Authors:  Jingtao Zhong; Xiaoming Yu; Xiaofeng Dong; Hong Lu; Wuyuan Zhou; Lei Li; Zhongchao Li; Pengfei Sun; Xuetao Shi
Journal:  Oncol Lett       Date:  2018-03-07       Impact factor: 2.967

Review 9.  Protective Effects of PACAP in Peripheral Organs.

Authors:  Denes Toth; Edina Szabo; Andrea Tamas; Tamas Juhasz; Gabriella Horvath; Eszter Fabian; Balazs Opper; Dora Szabo; Grazia Maugeri; Agata G D'Amico; Velia D'Agata; Viktoria Vicena; Dora Reglodi
Journal:  Front Endocrinol (Lausanne)       Date:  2020-07-14       Impact factor: 5.555

Review 10.  Pituitary Adenylate Cyclase-Activating Polypeptide: 30 Years in Research Spotlight and 600 Million Years in Service.

Authors:  Viktoria Denes; Peter Geck; Adrienn Mester; Robert Gabriel
Journal:  J Clin Med       Date:  2019-09-18       Impact factor: 4.241

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.